Sponsor study identifier
observational
1,000
1 country
1
Study Start
January 1, 2012
Actual (reported)Primary Completion
December 31, 2016
Actual (reported)Study Completion
December 31, 2016
Actual (reported)Incidence of End Stage Renal Disease (ESRD) amongst elderly patient group is continuously increasing with population aging progressing. Mineral and bone disorder (MBD) is a common complication caused by ESRD, it raises the incidence of cardiovascular disease (CVD) in hemodialysis patients, as well as mortality. Joint effects of Kidney failure and aging on elderly hemodialysis patients make the contribution factors of CKD-MBD quite complex, and it also leads to differences in clinic manifestation between elderly hemodialysis patients and non-elderly hemodialysis patients. Since not much studies had been done for this specific subject, thus, research on elderly patients who is taking Maintenance hemodialysis is very necessary. This study is a retrospective research to identify optimized target value of Calcium and Phosphorus for elderly patients taking maintenance hemodialysis and hence provide guidance for clinical practices. The data for this study will be provided by Beijing Blood Purification Quality Control and Improvement Center. Clinical files and Calcium and Phosphorus metabolic indices will be collected amongst elderly patients who were elder than 65 years and was taking maintenance hemodialysis between Jan 1st, 2012 through Dec 31st, 2016. Relationship between Calcium level, Phosphorus level, iPTH index, all-cause mortality and CVD caused mortality will be analyzed to identify optimized range of target Calcium levels, Phosphorus level for hemodialysis treatment
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
December 31, 2016
Actual (reported)Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
January 1, 2012
Actual (reported)December 31, 2016
Actual (reported)December 31, 2016
Actual (reported)August 23, 2017
Actual (reported)August 24, 2017
Actual (reported)All-cause mortality
all patients died in our observation period
5 years
CVD-related mortality
5 years
the data for this study will be provided by Beijing Blood Purification Quality Control and Improvement Center. Clinical files and Calcium and Phosphorus metabolic indices will be collected amongst elderly patients who were elder than 65 years and was taking maintenance hemodialysis between Jan 1st, 2012 through Dec 31st, 2016.
Beijing Friendship hospital
Beijing, Beijing Municipality, 100050, China
1,000 participants (actual enrollment reported by the registry).
First Submitted
August 23, 2017
First Posted
August 24, 2017
Study Start
January 1, 2012
Actual (reported)Renal Sympathetic Modification in Patients With Chronic Renal Failure
Contact the study team to confirm eligibility.
Primary Completion
December 31, 2016
Actual (reported)Study Completion
December 31, 2016
Actual (reported)Last Updated
August 24, 2017
Record last verified: 2017-08
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: